Benitec Biopharma Inc. Common Stock (BNTC) is a publicly traded Healthcare sector company. As of July 28, 2026, BNTC trades at $12.03 with a market cap of $394.04M and a P/E ratio of -11.01. BNTC moved +0.00% today. Year to date, BNTC is -14.03%; over the trailing twelve months it is +3.58%. Its 52-week range spans $9.49 to $17.15. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces BNTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BNTC, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $12.03 |
| Market Cap | $394.04M |
| P/E Ratio | -11.01 |
| EPS | $-1.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $9.49 |
| Volume | 3.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-37.92M |
| Gross Margin | 0.00% |
5 analysts cover BNTC: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.00.